Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - iBio, Inc. | tm2024769d1_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - iBio, Inc. | tm2024769d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - iBio, Inc. | tm2024769d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - iBio, Inc. | tm2024769d1_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - iBio, Inc. | tm2024769d1_ex23-1.htm |
| EX-4.9 - EXHIBIT 4.9 - iBio, Inc. | tm2024769d1_ex4-9.htm |
| 10-K - FORM 10-K - iBio, Inc. | tm2024769d1_10k.htm |
Exhibit 21.1
Subsidiaries of Registrant
iBioDefense Biologics LLC (“iBioDefense”) is wholly-owned and incorporated in Delaware
iBio Peptide Therapeutics LLC (“iBio Peptide”) is wholly-owned and incorporated in Delaware
iBio Manufacturing LLC (“iBio Manufacturing”) is wholly-owned and incorporated in Delaware
IBIO DO BRASIL BIOFARMACÊUTICA LTDA (“iBio Brazil”) is organized in Brazil (99% ownership interest)
iBio CDMO LLC (“iBio CDMO”) is registered in Texas and was originally named iBio CMO LLC (99.99% ownership interest). Name was changed effective July 1, 2017.